|
1
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kapranov P, Cheng J, Dike S, Nix DA,
Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J,
Hofacker IL, et al: RNA maps reveal new RNA classes and a possible
function for pervasive transcription. Science. 316:1484–1488. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmitt AM and Chang HY: Long Noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomas J, Ohtsuka M, Pichler M and Ling H:
MicroRNAs: Clinical relevance in colorectal cancer. Int J Mol Sci.
16:28063–28076. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee JS: The mutational landscape of
hepatocellular carcinoma. Clin Mol Hepatol. 21:220–229. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet 15 Spec No. 1:R17–R29. 2006. View Article : Google Scholar
|
|
8
|
Han D, Wang M, Ma N, Xu Y, Jiang Y and Gao
X: Long noncoding RNAs: Novel players in colorectal cancer. Cancer
Lett. 361:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Song YX and Wang ZN: Non-coding
RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li R, Zhu H and Luo Y: Understanding the
functions of long non-coding RNAs through their higher-order
structures. Int J Mol Sci. 17:E7022016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J,
Zhang Y, Chen J, Shen H and Hu Z: A genetic variant in long
non-coding RNA HULC contributes to risk of HBV-related
hepatocellular carcinoma in a Chinese population. PLoS One.
7:e351452012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hashad D, Elbanna A, Ibrahim A and Khedr
G: Evaluation of the role of circulating long non-coding RNA H19 as
a promising novel biomarker in plasma of patients with gastric
cancer. J Clin Lab Anal. 30:1100–1105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du Z, Fei T, Verhaak RG, Su Z, Zhang Y,
Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal
clinically relevant long noncoding RNAs in human cancer. Nat Struct
Mol Biol. 20:908–913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Zhao H, Xu W, Bao S, Cheng L and
Sun J: Discovery and validation of immune-associated long
non-coding RNA biomarkers associated with clinically molecular
subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer.
16:162017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian
J, Zhang X and Fang JY: A long non-coding RNA signature to improve
prognosis prediction of colorectal cancer. Oncotarget. 5:2230–2242.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCleland ML, Mesh K, Lorenzana E, Chopra
VS, Segal E, Watanabe C, Haley B, Mayba O, Yaylaoglu M, Gnad F and
Firestein R: CCAT1 is an enhancer-templated RNA that predicts BET
sensitivity in colorectal cancer. J Clin Invest. 126:639–652. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun J, Chen X, Wang Z, Guo M, Shi H, Wang
X, Cheng L and Zhou M: A potential prognostic long non-coding RNA
signature to predict metastasis-free survival of breast cancer
patients. Sci Rep. 5:165532015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the united states in 2006–2010. Neuro Oncol. 15
Suppl 2:ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Devaux Y, Zangrando J, Schroen B, Creemers
EE, Pedrazzini T, Chang CP, Dorn GW II, Thum T and Heymans S:
Cardiolinc network: Long noncoding RNAs in cardiac development and
ageing. Nat Rev Cardiol. 12:415–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi H CPWgtnpfRtBBRC. 2014.
|
|
27
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsuiji H, Yoshimoto R, Hasegawa Y, Furuno
M, Yoshida M and Nakagawa S: Competition between a noncoding exon
and introns: Gomafu contains tandem UACUAAC repeats and associates
with splicing factor-1. Genes Cells. 16:479–490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rintala-Maki ND and Sutherland LC:
Identification and characterisation of a novel antisense non-coding
RNA from the RBM5 gene locus. Gene. 445:7–16. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin D, Pestova TV, Hellen CU and Tiedge H:
Translational control by a small RNA: Dendritic BC1 RNA targets the
eukaryotic initiation factor 4A helicase mechanism. Mol Cell Biol.
28:3008–3019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raveh E, Matouk IJ, Gilon M and Hochberg
A: The H19 Long non-coding RNA in cancer initiation, progression
and metastasis-a proposed unifying theory. Mol Cancer. 14:1842015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hao Y, Crenshaw T, Moulton T, Newcomb E
and Tycko B: Tumour-suppressor activity of H19 RNA. Nature.
365:764–767. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han D, Gao X, Wang M, Qiao Y, Xu Y, Yang
J, Dong N, He J, Sun Q, Lv G, et al: Long noncoding RNA H19
indicates a poor prognosis of colorectal cancer and promotes tumor
growth by recruiting and binding to eIF4A3. Oncotarget.
7:22159–22173. 2016.PubMed/NCBI
|
|
38
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai
Y, Wu D, Wang Y, Zhuang Z and Xia H: Increased level of H19 long
noncoding RNA promotes invasion, angiogenesis, and stemness of
glioblastoma cells. J Neurosurg. 124:129–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jia P, Cai H, Liu X, Chen J, Ma J, Wang P,
Liu Y, Zheng J and Xue Y: Long non-coding RNA H19 regulates glioma
angiogenesis and the biological behavior of glioma-associated
endothelial cells by inhibiting microRNA-29a. Cancer Lett.
381:359–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Y, Wu JJ, Lin XB, Bao Y, Chen ZH,
Zhang CR, Cai Z, Zhou JY, Ding MH, Wu XJ, et al: Differential
lncRNA expression profiles in recurrent gliomas compared with
primary gliomas identified by microarray analysis. Int J Clin Exp
Med. 8:5033–5043. 2015.PubMed/NCBI
|
|
42
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Poirier F, Chan C, Timmons P, Robertson
EJ, Evans MJ and Rigby PW: The murine H19 gene is activated during
embryonic stem cell differentiation in vitro and at the time of
implantation in the developing embryo. Development. 113:1105–1114.
1991.PubMed/NCBI
|
|
44
|
Venkatraman A, He XC, Thorvaldsen JL,
Sugimura R, Perry JM, Tao F, Zhao M, Christenson MK, Sanchez R, Yu
JY, et al: Maternal imprinting at the H19-Igf2 locus maintains
adult haematopoietic stem cell quiescence. Nature. 500:345–349.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yin Y, Wang H, Liu K, Wang F, Ye X, Liu M,
Xiang R, Liu N and Liu L: Knockdown of H19 enhances differentiation
capacity to epidermis of parthenogenetic embryonic stem cells. Curr
Mol Med. 14:737–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai
Y, Wu D, Wang Y, Zhuang Z and Xia H: Increased level of H19 long
noncoding RNA promotes invasion, angiogenesis, and stemness of
glioblastoma cells. J Neurosurg. 2016:129–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li W, Jiang P, Sun X, Xu S, Ma X and Zhan
R: Suppressing H19 modulates tumorigenicity and stemness in U251
and U87MG glioma cells. Cell Mol Neurobiol. 36:1219–1227. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma
X and Li W: Knockdown of long noncoding RNA H19 sensitizes human
glioma cells to temozolomide therapy. Onco Targets Ther.
9:3501–3509. 2016.PubMed/NCBI
|
|
49
|
Wang J, Pan Y, Wu J, Zhang C, Huang Y,
Zhao R, Cheng G, Liu J, Qin C, Shao P, et al: The association
between abnormal long Noncoding RNA MALAT-1 expression and cancer
lymph node metastasis: A meta-analysis. Biomed Res Int.
2016:18234822016.PubMed/NCBI
|
|
50
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhou Y, Xu X, Lv H, Wen Q, Li J, Tan L, Li
J and Sheng X: The Long Noncoding RNA MALAT-1 is highly expressed
in ovarian cancer and induces cell growth and migration. PLoS One.
11:e01552502016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Han T, Jiao F, Hu H, Yuan C, Wang L, Jin
ZL, Song WF and Wang LW: EZH2 promotes cell migration and invasion
but not alters cell proliferation by suppressing E-cadherin, partly
through association with MALAT-1 in pancreatic cancer. Oncotarget.
7:11194–11207. 2016.PubMed/NCBI
|
|
53
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P
and Wu JW: Long noncoding RNA MALAT1 associates with the malignant
status and poor prognosis in glioma. Tumour Biol. 36:3355–3359.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xiang J, Guo S, Jiang S, Xu Y, Li J, Li L
and Xiang J: Silencing of Long Non-coding RNA MALAT1 promotes
apoptosis of glioma cells. J Korean Med Sci. 31:688–694. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vassallo I, Zinn P, Lai M, Rajakannu P,
Hamou MF and Hegi ME: WIF1 re-expression in glioblastoma inhibits
migration through attenuation of non-canonical WNT signaling by
downregulating the lncRNA MALAT1. Oncogene. 35:12–21. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ma J, Wang P, Yao Y, Liu Y, Li Z, Liu X,
Li Z, Zhao X, Xi Z, Teng H, et al: Knockdown of long non-coding RNA
MALAT1 increases the blood-tumor barrier permeability by
up-regulating miR-140. Biochim Biophys Acta. 1859:324–338. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Han Y, Wu Z, Wu T, Huang Y, Cheng Z, Li X,
Sun T, Xie X, Zhou Y and Du Z: Tumor-suppressive function of long
noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and
inactivation of ERK/MAPK signaling. Cell Death Dis. 7:e21232016.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cai B, Song XQ, Cai JP and Zhang S:
HOTAIR: A cancer-related long non-coding RNA. Neoplasma.
61:379–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Fu WM, Zhu X, Wang WM, Lu YF, Hu BG, Wang
H, Liang WC, Wang SS, Ko CH, Waye MM, et al: Hotair mediates
hepatocarcinogenesis through suppressing miRNA-218 expression and
activating P14 and P16 signaling. J Hepatol. 63:886–895. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al: HOTAIR, a cell
cycle-associated long noncoding RNA and a strong predictor of
survival, is preferentially expressed in classical and mesenchymal
glioma. Neuro Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhou X, Ren Y, Zhang J, Zhang C, Zhang K,
Han L, Kong L, Wei J, Chen L, Yang J, et al: HOTAIR is a
therapeutic target in glioblastoma. Oncotarget. 6:8353–8365.
2015.PubMed/NCBI
|
|
65
|
Fang K, Liu P, Dong S, Guo Y, Cui X, Zhu
X, Li X, Jiang L, Liu T and Wu Y: Magnetofection based on
superparamagnetic iron oxide nanoparticle-mediated low lncRNA
HOTAIR expression decreases the proliferation and invasion of
glioma stem cells. Int J Oncol. 49:509–518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ke J, Yao YL, Zheng J, Wang P, Liu YH, Ma
J, Li Z, Liu XB, Li ZQ, Wang ZH and Xue YX: Knockdown of long
non-coding RNA HOTAIR inhibits malignant biological behaviors of
human glioma cells via modulation of miR-326. Oncotarget.
6:21934–21949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yang B, Wei ZY, Wang BQ, Yang HC, Wang JY
and Bu XY: Down-regulation of the long noncoding RNA-HOX transcript
antisense intergenic RNA inhibits the occurrence and progression of
glioma. J Cell Biochem. 119:2278–2287. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bian EB, Ma CC, He XJ, Wang C, Zong G,
Wang HL and Zhao B: Epigenetic modification of miR-141 regulates
SKA2 by an endogenous ‘sponge’ HOTAIR in glioma. Oncotarget.
7:30610–30625. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang G, Li Z, Tian N, Han L, Fu Y, Guo Z
and Tian Y: miR-148b-3p inhibits malignant biological behaviors of
human glioma cells induced by high HOTAIR expression. Oncol Lett.
12:879–886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Graham LD, Pedersen SK, Brown GS, Ho T,
Kassir Z, Moynihan AT, Vizgoft EK, Dunne R, Pimlott L, Young GP, et
al: Colorectal neoplasia differentially expressed (CRNDE), a novel
gene with elevated expression in colorectal adenomas and
adenocarcinomas. Genes Cancer. 2:829–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ellis BC, Molloy PL and Graham LD: CRNDE:
A long non-coding RNA involved in cancer, neurobiology, and
development. Front Genet. 3:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kiang K, Zhang XQ and Leung GK: Long
non-coding RNAs: The key players in glioma pathogenesis. Cancers
(Basel). 7:1406–1424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zheng J, Liu X, Wang P, Xue Y, Ma J, Qu C
and Liu Y: CRNDE promotes malignant progression of glioma by
attenuating miR-384/PIWIL4/STAT3 axis. Mol Ther. 24:1199–1215.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Palmieri G, Paliogiannis P, Sini MC, Manca
A, Palomba G, Doneddu V, Tanda F, Pascale MR and Cossu A: Long
non-coding RNA CASC2 in human cancer. Crit Rev Oncol Hematol.
111:31–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J
and Xue YX: Long non-coding RNA CASC2 suppresses malignancy in
human gliomas by miR-21. Cell Signal. 27:275–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liao Y, Shen L, Zhao H, Liu Q, Fu J, Guo
Y, Peng R and Cheng L: LncRNA CASC2 interacts with miR-181a to
modulate glioma growth and resistance to TMZ through PTEN pathway.
J Cell Biochem. 118:1889–1899. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Balci T, Yilmaz Susluer S, Kayabasi C,
Ozmen Yelken B, Biray Avci C and Gunduz C: Analysis of dysregulated
long non-coding RNA expressions in glioblastoma cells. Gene.
590:120–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Liu Q, Sun S, Yu W, Jiang J, Zhuo F, Qiu
G, Xu S and Jiang X: Altered expression of long non-coding RNAs
during genotoxic stress-induced cell death in human glioma cells. J
Neurooncol. 122:283–292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhang L, Liang X and Li Y: Long non-coding
RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and
inactivating PI3K/AKT pathway. Oncol Rep. 38:2408–2416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Reon BJ, Anaya J, Zhang Y, Mandell J,
Purow B, Abounader R and Dutta A: Expression of lncRNAs in
low-grade gliomas and glioblastoma multiforme: An In silico
analysis. PLoS Med. 13:e10021922016. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang XQ, Kiang KM, Wang YC, Pu JK, Ho A,
Cheng SY, Lee D, Zhang PD, Chen JJ, Lui WM, et al: IDH1
mutation-associated long non-coding RNA expression profile changes
in glioma. J Neurooncol. 125:253–263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang W, Yang F, Zhang L, Chen J, Zhao Z,
Wang H, Wu F, Liang T, Yan X, Li J, et al: LncRNA profile study
reveals four-lncRNA signature associated with the prognosis of
patients with anaplastic gliomas. Oncotarget. 7:77225–77236.
2016.PubMed/NCBI
|
|
89
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: lncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Arun G, Diermeier S, Akerman M, Chang KC,
Wilkinson JE, Hearn S, Kim Y, MacLeod AR, Krainer AR, Norton L, et
al: Differentiation of mammary tumors and reduction in metastasis
upon Malat1 lncRNA loss. Genes Dev. 30:34–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Amit D, Matouk IJ, Lavon I, Birman T,
Galula J, Abu-Lail R, Schneider T, Siegal T, Hochberg A and Fellig
Y: Transcriptional targeting of glioblastoma by diphtheria toxin-A
driven by both H19 and IGF2-P4 promoters. Int J Clin Exp Med.
5:124–135. 2012.PubMed/NCBI
|
|
92
|
Pastori C, Kapranov P, Penas C, Peschansky
V, Volmar CH, Sarkaria JN, Bregy A, Komotar R, St Laurent G, Ayad
NG and Wahlestedt C: The Bromodomain protein BRD4 controls HOTAIR,
a long noncoding RNA essential for glioblastoma proliferation. Proc
Natl Acad Sci USA. 112:pp. 8326–8331. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
93
|
García-Claver A, Lorente M, Mur P,
Campos-Martín Y, Mollejo M, Velasco G and Meléndez B: Gene
expression changes associated with erlotinib response in glioma
cell lines. Eur J Cancer. 49:1641–1653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Shi C, Zhang L and Qin C: Long non-coding
RNAs in brain development, synaptic biology, and Alzheimer's
disease. Brain Res Bull. 132:160–169. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Subhramanyam CS and Hu Q: Non-coding rna
in brain development and disorder. Curr Med Chem. 24:1983–1997.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Hassan A, Mosley J, Singh S and Zinn PO: A
comprehensive review of genomics and noncoding RNA in gliomas. Top
Magn Reson Imaging. 26:3–14. 2017.PubMed/NCBI
|
|
97
|
Hu L, Lv QL, Chen SH, Sun B, Qu Q, Cheng
L, Guo Y, Zhou HH and Fan L: Up-Regulation of long non-coding RNA
AB073614 predicts a poor prognosis in patients with glioma. Int J
Environ Res Public Health. 13:4332016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan
G and Jiang Y: HULC long noncoding RNA silencing suppresses
angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling
pathway in human gliomas. Oncotarget. 7:14429–14440.
2016.PubMed/NCBI
|
|
99
|
He C, Jiang B, Ma J and Li Q: Aberrant
NEAT1 expression is associated with clinical outcome in high grade
glioma patients. APMIS. 124:169–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhen L, Yun-Hui L, Hong-Yu D, Jun M and
Yi-Long Y: Long noncoding RNA NEAT1 promotes glioma pathogenesis by
regulating miR-449b-5p/c-Met axis. Tumour Biol. 37:673–683. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Guo H, Wu L, Yang Q, Ye M and Zhu X:
Functional linc-POU3F3 is overexpressed and contributes to
tumorigenesis in glioma. Gene. 554:114–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Liu H, Lv Z and Guo E: Knockdown of long
noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation,
metastasis and epithelial-mesenchymal transition. Int J Clin Exp
Pathol. 8:9140–9146. 2015.PubMed/NCBI
|
|
103
|
Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J,
Chen L, Xi Z, Teng H, Wang Z, et al: Knockdown of long non-coding
RNA XIST exerts tumor-suppressive functions in human glioblastoma
stem cells by up-regulating miR-152. Cancer Lett. 359:75–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu
Y and Zhu W: A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated
by DNMT1 and inhibits migration of glioma cells. Tumour Biol.
35:7935–7944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Li J, Bian EB, He XJ, Ma CC, Zong G, Wang
HL and Zhao B: Epigenetic repression of long non-coding RNA MEG3
mediated by DNMT1 represses the p53 pathway in gliomas. Int J
Oncol. 48:723–733. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Qin X, Yao J, Geng P, Fu X, Xue J and
Zhang Z: LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.
Int J Clin Exp Pathol. 7:3065–3072. 2014.PubMed/NCBI
|
